Fmr LLC Cogent Biosciences, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 17,078,468 shares of COGT stock, worth $277 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,078,468

Previous 17,077,329 0.01%

Holding current value

$277 Million

Previous $102 Million 19.87%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$4.02 - $7.51 $4,578 - $8,553	1,139 Added 0.01%	17,078,468 $123 Million
Q1 2025 May 12, 2025	BUY	$5.99 - $9.66 $3.04 Million - $4.91 Million	508,073 Added 3.07%	17,077,329 $102 Million
Q4 2024 Feb 13, 2025	BUY	$7.64 - $12.28 $63 Million - $101 Million	8,249,845 Added 99.16%	16,569,256 $129 Million
Q3 2024 Nov 13, 2024	BUY	$8.24 - $11.48 $5.16 Million - $7.18 Million	625,743 Added 8.13%	8,319,411 $89.8 Million
Q2 2024 Aug 13, 2024	BUY	$6.01 - $9.04 $4.38 Million - $6.59 Million	729,060 Added 10.47%	7,693,668 $64.9 Million
Q1 2024 May 13, 2024	BUY	$4.38 - $9.02 $7.28 Million - $15 Million	1,661,754 Added 31.34%	6,964,608 $46.8 Million
Q4 2023 Feb 13, 2024	BUY	$4.06 - $10.08 $2.98 Million - $7.39 Million	733,073 Added 16.04%	5,302,854 $31.2 Million
Q3 2023 Nov 13, 2023	BUY	$9.69 - $13.34 $41.2 Million - $56.7 Million	4,248,521 Added 1322.46%	4,569,781 $44.6 Million
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.24 $2.71 Million - $3.65 Million	275,620 Added 603.9%	321,260 $3.8 Million
Q1 2023 May 11, 2023	SELL	$10.04 - $15.5 $11 Million - $17 Million	-1,095,851 Reduced 96.0%	45,640 $492,000
Q4 2022 Feb 13, 2023	SELL	$10.65 - $14.84 $1.68 Million - $2.34 Million	-157,552 Reduced 12.13%	1,141,491 $13.2 Million
Q3 2022 Nov 10, 2022	BUY	$9.39 - $16.99 $419,667 - $759,334	44,693 Added 3.56%	1,299,043 $19.4 Million
Q2 2022 Aug 12, 2022	BUY	$3.92 - $9.73 $3.3 Million - $8.2 Million	842,796 Added 204.78%	1,254,350 $11.3 Million
Q1 2022 May 13, 2022	BUY	$5.31 - $8.7 $119,055 - $195,062	22,421 Added 5.76%	411,554 $3.08 Million
Q4 2021 Feb 14, 2022	BUY	$7.51 - $10.81 $2.92 Million - $4.21 Million	389,046 Added 447179.31%	389,133 $3.34 Million
Q3 2021 Nov 15, 2021	BUY	$5.99 - $9.14 $521 - $795	87 New	87 $0

Others Institutions Holding COGT

# of Institutions

203

Shares Held

118M

Call Options Held

2.84M

Put Options Held

828K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $1.07B
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account